iShares US Pharmaceuticals ETF (IHE) closed at $102.51 on October 23, 2026, down 2.2% from the previous close, on volume of 125,794 shares (30-day average 240,080).
Data as of October 23, 2026.
23-Oct-2026
No headlines found.
No press releases found.
No news found.
The iShares Dow Jones U.S. Pharmaceuticals Index Fund seeks investment results that correspond generally to the price and yield performance before fees and expenses of the Dow Jones U.S. Select Pharmaceuticals Index.
iShares US Pharmaceuticals ETF trades on the ARCA stock market under the symbol IHE.
As of October 23, 2026, IHE stock price declined to $102.51 with 125,794 million shares trading.
IHE has a beta of 0.12, meaning it tends to be less sensitive to market movements. IHE has a correlation of 0.01 to the broad based SPY ETF.
IHE has a market cap of $1.54 billion. This is considered a Small Cap stock.
In the last 3 years, IHE traded as high as $108.66 and as low as $55.36.
IHE has outperformed the market in the last year with a price return of +38.9% while the SPY ETF gained +14.3%. However, in the short term, IHE had mixed performance relative to the market. It has underperformed in the last 3 months, returning +0.8% vs +3.2% return in SPY. But in the last 2 weeks, IHE shares have fared better than the market returning +2.4% compared to SPY -2.4%.
IHE support price is $103.33 and resistance is $106.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IHE shares will trade within this expected range on the day.
